Product Details:
| Minimum Order Quantity | 10 Vial |
| Strength | 2.5 mg |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro |
| Manufacturer | Lilly |
| Prescription | No |
| Usage / Application | Diabetes |
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Box |
| Strength | 5 mg |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro |
| Manufacturer | Lilly |
| Prescription | No |
Mounjaro 5mg KwikPen is a prescription medication designed for once-weekly subcutaneous injection to help adults with type 2 diabetes manage their blood sugar levels effectively. Its active ingredient, tirzepatide, is a dual receptor agonist targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This places Mounjaro in a newer class of antidiabetic drugs known as incretin mimetics, which mimic the action of natural gut hormones involved in blood sugar regulation.
Mounjaro is intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose. The KwikPen device is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength, meaning a 5mg pen holds a total of 20mg of tirzepatide (4 doses x 5mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month. This convenient dosing schedule helps maintain steady blood levels and simplifies treatment.
This medication is specifically indicated for type 2 diabetes and should not be used for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) must avoid this treatment. Always use Mounjaro under the supervision of a qualified healthcare provider.
UsesMounjaro 5mg KwikPen is approved for:
Improving blood sugar control in adults with type 2 diabetes mellitus
Used in combination with diet and exercise
May be used alone or with other diabetes medications
Note: It is not approved for weight loss or for use in type 1 diabetes.
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Vial |
| Strength | 2.5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Injection |
| Brand | Mounjaro |
| Manufacturer | Lilly |
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Vial |
| Strength | 5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Injection |
| Brand | Mounjaro |
| Manufacturer | Lilly |
Additional Information: